In addition, our in vitro experiments also demonstrated that the ZEB2 expression of UM-Chor1 was significantly downregulated after the application of inhibitors, which targeted TGFBI, and the invasiveness of tumor cells was correspondingly attenuated. The gene discussed is ZEB2; the disease is neoplasm.